Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
"Waging War on Cancer"
Winston-Salem Journal Editorial, August 8, 2007
Located in News / 2011 News
Donald Rosenstein serves as president of Academy of Psychosomatic Medicine
Donald Rosenstein, MD, professor of psychiatry and medicine in the UNC School of Medicine and director of the UNC Comprehensive Cancer Support Program, will serve a one-year term as president of the Academy of Psychosomatic Medicine. Dr. Rosenstein is a member of UNC Lineberger Comprehensive Cancer Center.
Located in News / 2011 News
Liquidia announces product development collaboration with GlaxoSmithKline
Newly-Formed Collaboration to Focus on Vaccines and Inhaled Therapeutics
Located in News / 2012 News
STO receives grant for annual meeting, event to be held at UNC Lineberger
The North Carolina Biotechnology Center recently awarded the Society for Translational Oncology (STO) $5,000 to be used for the organization's annual meeting. This year's meeting "Personalizing Cancer Diagnosis and Treatment 2012" will be held October 20-21 at UNC Lineberger.
Located in News / 2012 News
N.C. Cancer Hospital on “Great Oncology Program” list
Becker's Hospital Review has named the N.C Cancer Hospital as one of "70 Hospitals with Great Oncology Programs."
Located in News / 2012 News
A Summer Final Four: Help Cornucopia House Win $25,000
Votes, not baskets, will propel Cornucopia House to the Final Four in a national competition for a $25K mobile technology grant from AtlanticBT.
Located in News / 2012 News
DeSimone Receives Innovation Award
Located in News / 2011 News
Mayer appointed to term on Cancer Survivorship Committee
Deborah Mayer, PhD, RN, AOCN, FAAN, associate professor in the UNC School of Nursing, has been appointed to a three-year term on the Cancer Survivorship Committee of the American Society of Clinical Oncology.
Located in News / 2012 News
Kinase test may yield big gains for drug-resistant cancers
Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse”, enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.
Located in News / 2012 News
Multidisciplinary research urged for optimal melanoma surgery
UNC surgical oncologist co-authors Lancet editorial
Located in News / 2011 News